AyuVis Joins BLUE KNIGHT™ Initiative for Drug Development Advancement

AyuVis Research, Inc. has been chosen to be a part of BLUE KNIGHT™, a collaborative venture between Johnson & Johnson Innovation – JLABS and the Biomedical Advanced Research and Development Authority (BARDA), an entity within the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS). Additionally, AyuVis has received an invitation for a virtual residency at JLABS @ TMC, situated at the Texas Medical Center in Houston. Participation in these initiatives is poised to bolster AyuVis’ drug development program expansion and facilitate the pursuit of further non-dilutive funding opportunities.